Literature DB >> 20510241

Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment.

Mariana J Kaplan1.   

Abstract

Morbidity and mortality rates are higher in individuals with rheumatoid arthritis (RA) than in the general population. Ischemic heart disease and heart failure now represent one of the most common causes of death in RA. Indeed, RA appears to represent an independent risk factor for ischemic heart disease, similar to diabetes mellitus. However, no clear guidelines with regard to cardiovascular disease diagnosis and prevention in RA have been developed. This review highlights recent investigations on the assessment, prevention, and treatment of cardiovascular disease in RA.

Entities:  

Mesh:

Year:  2010        PMID: 20510241      PMCID: PMC2892739          DOI: 10.1016/j.rdc.2010.02.002

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  162 in total

1.  Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction.

Authors:  Lorenz M Fischer; Raymond G Schlienger; Christian M Matter; Hershel Jick; Christoph R Meier
Journal:  Arch Intern Med       Date:  2004 Dec 13-27

2.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

3.  Acceleration of atherosclerosis during the course of rheumatoid arthritis.

Authors:  Inmaculada Del Rincón; Daniel H O'Leary; Gregory L Freeman; Agustín Escalante
Journal:  Atherosclerosis       Date:  2006-11-13       Impact factor: 5.162

4.  Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis.

Authors:  S S Jick; H Choi; L Li; I B McInnes; N Sattar
Journal:  Ann Rheum Dis       Date:  2008-07-28       Impact factor: 19.103

5.  Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients.

Authors:  P I Sidiropoulos; P Siakka; K Pagonidis; A Raptopoulou; H Kritikos; D Tsetis; D T Boumpas
Journal:  Scand J Rheumatol       Date:  2009 Jan-Feb       Impact factor: 3.641

Review 6.  Is atherosclerosis a complication of long-term corticosteroid treatment?

Authors:  D J Nashel
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965

7.  Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis.

Authors:  Patrick H Dessein; Gavin R Norton; Angela J Woodiwiss; Barry I Joffe; Fred Wolfe
Journal:  J Rheumatol       Date:  2007-04-15       Impact factor: 4.666

8.  Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

Authors:  Joachim Listing; Anja Strangfeld; Jörn Kekow; Matthias Schneider; Andreas Kapelle; Siegfried Wassenberg; Angela Zink
Journal:  Arthritis Rheum       Date:  2008-03

9.  Atherothrombotic events in rheumatoid arthritis are predicted by homocysteine - a six-year follow-up study.

Authors:  S Berglund; A Södergren; S Wållberg Jonsson; S Rantapää Dahlqvist
Journal:  Clin Exp Rheumatol       Date:  2009 Sep-Oct       Impact factor: 4.473

10.  Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.

Authors:  David Hürlimann; Adrian Forster; Georg Noll; Frank Enseleit; Rémy Chenevard; Oliver Distler; Markus Béchir; Lukas E Spieker; Michel Neidhart; Beat A Michel; Renate E Gay; Thomas F Lüscher; Steffen Gay; Frank Ruschitzka
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

View more
  37 in total

Review 1.  Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel "first-in-class" anti-inflammatory drug candidates: a reviewer's perspective.

Authors:  Geetha Mathew; M K Unnikrishnan
Journal:  Inflamm Res       Date:  2015-07-18       Impact factor: 4.575

2.  Rheumatoid arthritis and atypical cardiovascular disease: inflammation changing the clinical presentation.

Authors:  Marco Iafolla
Journal:  Can Fam Physician       Date:  2013-05       Impact factor: 3.275

3.  Positive effect of hydroxychloroquine on lipid profiles of patients with rheumatoid arthritis: A Veterans Affair cohort.

Authors:  Myriam Guevara; Bernard Ng
Journal:  Eur J Rheumatol       Date:  2020-11-05

Review 4.  Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus.

Authors:  J Michelle Kahlenberg; Mariana J Kaplan
Journal:  Annu Rev Med       Date:  2012-09-27       Impact factor: 13.739

5.  Body composition in patients with rheumatoid arthritis is not different than healthy subjects.

Authors:  Servet Akar; İsmail Sarı; Abdurrahman Çömlekci; Merih Birlik; Fatoş Önen; Yiğit Göktay; Dinc Özaksoy; Nurullah Akkoç
Journal:  Eur J Rheumatol       Date:  2014-09-01

6.  Evaluation of serum magnesium, lipid profile and various biochemical parameters as risk factors of cardiovascular diseases in patients with rheumatoid arthritis.

Authors:  Vilas U Chavan; Dvss Ramavataram; Payal A Patel; Mihir P Rupani
Journal:  J Clin Diagn Res       Date:  2015-04-01

7.  High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.

Authors:  Anuradha Vivekanandan-Giri; Jessica L Slocum; Jaeman Byun; Chongren Tang; Robin L Sands; Brenda W Gillespie; Jay W Heinecke; Rajiv Saran; Mariana J Kaplan; Subramaniam Pennathur
Journal:  Ann Rheum Dis       Date:  2013-01-12       Impact factor: 19.103

8.  Pericardial mass in a patient with rheumatoid arthritis.

Authors:  Mohammad Al-Ani; Michelle Weber; David Winchester; Matthew Kosboth
Journal:  BMJ Case Rep       Date:  2015-06-08

Review 9.  Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity.

Authors:  Nicolas Vuilleumier; Fabrizio Montecucco; Oliver Hartley
Journal:  World J Cardiol       Date:  2014-05-26

Review 10.  Biventricular thrombus and associated myocardial infarction in a rheumatoid arthritis patient: a case report and literature review.

Authors:  Eser Açıkgöz; Cağrı Yayla; Sadık Kadri Açıkgöz; Asife Sahinarslan
Journal:  Clin Rheumatol       Date:  2013-04-11       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.